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INTRODUCTION 
The earliest recognition in the medical literature of a syndrome 
characterized by cirrhosis, diabetes mellitus, and melanoderma was in 
a lecture on diabetes by Trousseau in 1865 (1). Von Recklinghausen in 
1889 coined the name now most commonly used to designate this entity: 
hemochromatosis (2). More recently, Sheldon published in 1935 a mono¬ 
graph which provided a comprehensive review of the clinical, pathologic, 
and investigative experience with hemochromatosis. This work, by suggest¬ 
ing that the disease represented an inborn error of metabolism, gave im¬ 
petus to the further study of possible genetic and metabolic pathogenic 
factors (3). 
Despite the length of time that hemochromatosis has been recognized 
and studied, a theory generally accepted as explaining satisfactorily 
its etiology and pathogenesis has thus far not been evolved. As indi¬ 
cated by the context in which Trousseau first mentioned hemochromatosis, 
the earliest students of the disease considered it simply an interesting 
variant of diabetes (4). Many other etiologic possibilities were sub¬ 
sequently suggested, but most present-day theories have been derived 
from the concept of Sheldon that the primary abnormality is an inborn 
error of iron metabolism (3). According to workers following Sheldon, 
this metabolic error causes an enormously increased absorption of iron 
through the intestinal mucosa (5). These concepts have been included in 
two of the most recent theories, which differ, however, in the importance 
attributed to the ultimate accumulation of iron in the tissues. Finch 
and Finch consider the manifestations of hemochromatosis as results of the 
tissue damage produced directly by cellular iron loading (6). According 
to Dubin, however, the same metabolic error causes both increased iron 
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absorption and, independently, fibrosis of the liver and pancreas result¬ 
ing in the clinical features of hemochromatosis (7). 
The close association of portal cirrhosis with hemochromatosis has 
long been recognized (3). Some writers have considered portal cirrhosis 
the sole cause of hemochromatosis, which they regard as a variant of this 
type of cirrhosis, but most authors merely have mentioned the similarity 
of the histopathology in the two diseases and the high incidence of 
’’harmless" tissue iron in typical portal cirrhosis (3,8,12). 
The present retrospective clinico-pathologic study was proposed to 
investigate further the relationship of portal cirrhosis to hemochromatosis, 
hoping ultimately to understand better the nature of the latter's etiology 
and pathogenesis. Specific areas to be explored in reference to patients 
with portal cirrhosis were: (1) the incidence of stainable parenchymal 
and reticuloendothelial hepatic iron, (2) the relation of the degree of 
hepatic siderosis to hepatic structural and functional damage, (3) the 
correlation of the incidence of pancreatic with hepatic iron, (4) the 
relation of pancreatic iron to pancreatic fibrosis, and (5) the correlation 
of the incidence of splenic with hepatic iron. 
MATERIALS AND METHODS 
Case Selection and Pathologic Studies 
All cases with a primary or subsidiary post-mortem diagnosis of 
"hepatic fibrosis" or "cirrhosis" at the Yale-New Haven Medical Center in 
the years 1952-1959 were selected from the files of the Department of 
Pathology. From the 130 cases thus obtained microscopic sections were 
made of formalin-fixed liver, pancreas, and spleen. Liver sections were 
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prepared with Masson's trichrome stain; sections from all three organs 
were stained for iron (hemosiderin) with the Hubbell modification of the 
Gomori technique, using 2% hydrochloric acid and 2% potassium ferrocyanide 
(9). 
Liver sections from all cases were examined microscopically to sub¬ 
stantiate the diagnosis of cirrhosis; 88 cases remained in this category 
and were separated into two major groups: 60 cases with typical portal 
(Laennec's) cirrhosis and 28 with other specific types (post-necrotic, 
cardiac, and biliary) or unclassified cirrhosis. Diffuse monolobular 
fibrosis, small isolated regenerative nodules (pseudolobules), active 
parenchymal degeneration in the form of alcoholic hyaline (Mallory bodies"), 
and fatty hepatocellular changes, in the absence of congestive or bile 
duct alterations specific for cardiac or biliary cirrhosis, constituted 
the basis for the morphologic diagnosis of portal cirrhosis. In addition, 
a positive history of alcoholism was considered in evaluation of type of 
cirrhosis. 
Semiquantitative grading of hepatic iron content was established with 
emphasis on hepatocellular rather than reticuloendothelial (Kupffer cell) 
iron. Cases without hepatocellular iron were divided into those with no 
stainable liver iron and those with only Kupffer cell iron; cases with 
hepatocellular iron were graded from 1+ to 4+, the amount of coincident 
Kupffer cell iron being disregarded. In the final tabulation of results, 
cases with 1+ and 2+ hepatocellular iron were grouped as "slight," those 
with 3+ and 4+ as "marked." 
The extent of hepatic fibrosis was assessed by separating all cases 
into two groups: those with "moderate fibrosis" and those with "advanced 
fibrosis." Hepatocellular fat content was graded from 1+ to 4+. In the 
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final tabulation all cases having only a trace (1+) of fat were not included 
in the "significant fat" category. Marked involvement of hepatic parenchymal 
cells with clearcut alcoholic hyaline ("Mallory bodies") was noted. Also 
noted were liver sections containing typical "glycogen nuclei" (the 
nuclei appearing to contain single large empty vacuoles) (11). 
Stromal and parenchymal pancreatic iron content was assessed in a 
manner similar to that for hepatic iron and ranged from trace (1+) to mild 
(2+), excepting one case with moderate iron staining in a non-portal 
cirrhotic patient. Siderosis was tabulated only as being "present" or 
"absent." The location of the iron, whether in fibrous, acinar or islet 
tissue, was noted but not included in the final tabulation. 
Ferrocyanide-stained sections of pancreas could not be evaluated for 
fibrosis; instead, these data were obtained from the complete autopsy pro¬ 
tocols. 
The ferrocyanide-stained sections of spleen were evaluated for both 
the amount (from 1+ to 4+) and the location of iron. 1+ and 2+ iron 
were tabulated as "slight," 3+ and 4+ as ,5marked." 
Clinical Studies 
For the sixty patients with portal cirrhosis data regarding age, sex 
and race were available. However, hospital charts could be obtained for 
only 52 patients; the clinical data are based on the records of this group. 
Few charts were satisfactorily complete; many items in the history and 
physical examination were not mentioned and for some patients there were 
few laboratory data. 
The 55 white patients were considered separately by sex and by age 
relative to the median age for their sex. The median age proved to be 57 
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years for men and 49 years for women. The five Negro patients were con¬ 
sidered individually. 
All but two of the patients who admitted to excessive alcoholic in¬ 
take placed its duration at more than five years. The other two patients 
had drunk heavily for less than one year and were not included as chronic 
alcoholics. Dietary habits were poorly documented in the records; specific 
mention of several years' inadequate diet by the patient was a requisite 
for his inclusion in the "poor diet" category. 
Patients with a history of either ankle edema (even those with known 
cardiac disease) or ascites were listed as having "fluid retention." 
Those with a history of hematemesis or melena were included in the category 
of "GI bleeding." Clearcut symptoms and signs of cardiac failure or a 
definite diagnosis of congestive heart failure was accepted for inclusion 
of a patient in this category. Conversely, only those patients with a 
well-established diagnosis of diabetes mellitus were considered as having 
the disease. 
On the basis of physical examination patients were categorized as hav¬ 
ing "bronze pigmentation" whenever it was noted as present or doubtful. 
For inclusion of a patient in the group with "jaundice," however, his 
icterus had to be definite. "Hepatomegaly" included all those cases with 
livers felt to be 4 cm. (two fingerbreadths) or more enlarged. Ascites and 
edema, whatever the presumed cause, were considered as indicating "fluid re¬ 
tention." Patients were included in the "abnormal heart" grouping if they 
exhibited cardiomegaly, significant murmurs, or cardiac failure. Testi¬ 
cular atrophy, when described in the hospital record, was noted. 
Admission hematocrits were available on almost all patients with hos¬ 
pital charts; values under 30% (9 gm.70 hemoglobin) were considered as indi- 
.. 
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cating anemia. Serum iron determinations were available on only three 
patients and were so listed. Patients with elevated fasting blood sugars 
(more than 100 mg.%) or glycosuria (including a trace of glucose) during 
their hospital stay were carefully screened; those receiving intravenous 
infusions were not included in these tabulations. 
Patients receiving transfusions were given from 1 to 53 pints of 
blood; they were listed simply as having been "transfused." Patients 
with the clinical picture of congestive heart failure at any time during 
their hospital course were so listed. Those patients with advanced liver 
disease, mental obtundation and asterixis were considered to have "hepatic 
coma." Finally, patients with hematemesis, massive rectal bleeding or 
melena (as demonstrated by the guaiac test) were considered together in 
the group "GI bleeding." 
These detailed clinical features were not studied in the 28 cases 
of non-portal cirrhosis. 
RESULTS 
Table l 
The incidence of the various histologic characteristics studied in 
the liver, pancreas, and spleen in cases of portal cirrhosis are correlated 
with the extent of hepatic siderosis in Table 1. It is seen that 657, of 
the patients with portal cirrhosis exhibited stainable iron in the liver, 
42% having hepatocellular iron and 237, having iron solely in the Kupffer 
cells. As stated before, many of the livers containing hepatocellular 
iron also contained Kupffer cell iron. However, in a given case, the 
amount of reticuloendothelial iron as compared to the amount of parenchymal 
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iron was typically slight; in many liver sections with mild to moderate 
hepatocellular siderosis no Kupffer cell iron could be found. 
The extent of hepatic fibrosis apparently correlated with the ex¬ 
tent of hepatocellular siderosis, the incidence of advanced fibrosis being 
407, in cases without hepatocellular iron, 507, in those with slight hep¬ 
atocellular iron, and 717, in cases with marked hepatocellular iron. In 
contrast, there was no relation between the incidence of Kupffer cell 
siderosis and the incidence of advanced fibrosis, the latter condition 
occurring in 36% of cases with only Kupffer cell iron and in 43% of those 
with no hepatic iron. 
In evaluating the extent of hepatocellular fat, it seemed that the 
fat content varied inversely as the extent of fibrosis. This impression 
was strengthened by the low incidence (29%) of fat in cases with marked 
hepatocellular iron as compared to those without hepatocellular iron (707,). 
The significance of the high (83%) correlation of fat with slight hepato¬ 
cellular siderosis is unclear. Fatty hepatocellular changes appeared about 
equally frequent in the livers with only Kupffer cell iron (647,) and in 
those without (7670). 
No alcoholic hyaline was found in livers with hepatocellular iron. 
However, the incidence of these cytoplasmic changes was not significantly 
decreased in cases with only Kupffer cell iron (21%) as compared to those 
with no liver iron (247o). 
The incidence of "glycogen nuclei" was greatly increased in the pres¬ 
ence of hepatocellular siderosis. These nuclear changes occurred in 57, 
of cases with no hepatocellular iron, in 17% of those with slight and 
43% of cases with marked hepatocellular iron. 
There was a strong correlation between the presence of hepatocellular 
and pancreatic siderosis. In none of the 14 cases with only Kupffer cell 
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iron and in one of the 21 with no hepatic iron was pancreatic iron encoun¬ 
tered. This was in contrast to the frequency of pancreatic siderosis in 
patients with slight (407.) and marked (67%) hepatocellular siderosis, The 
extent of pancreatic siderosis was never great, the amount of iron in the 
most severely affected pancreas corresponding roughly to 2+ (mild) hepatic 
involvement. The location of the iron was inconstant, the acinar tissue, 
however, being more affected than the fibrous tissue. Of especial inter¬ 
est, the islets were rarely and minimally involved. 
The incidence of pancreatic fibrosis seemed not to be related to the 
extent of hepatocellular siderosis and was actually less in the patients 
with Kupffer cell iron (12%) than in those with no hepatic iron (64%). 
Of the 21 cases with no hepatic iron, splenic siderosis was absent 
in 40%, slight in 50%, and marked in 107,. In the groups with only Kupffer 
cell iron and with slight hepatocellular iron, which were identical re¬ 
garding frequency and extent of splenic siderosis, cases without splenic 
iron were much less frequent (770). This lower incidence was associated 
with a greater incidence of slight splenic siderosis (78%); marked splenic 
siderosis remained uncommon (147,). The six cases of marked hepatocellular 
siderosis were associated with a striking increase in splenic iron. In 
one case there was no splenic iron; in two there was slight., and in three, 
marked splenic involvement with iron. In contrast to the situation in 
the pancreas, the location of the iron in the spleen showed great uniform¬ 
ity. In all cases the hemosiderin deposits were restricted to the red pulp-- 
the white pulp (Malpighian corpuscles), blood vessels, and trabeculae being 
spared. 
Table 2 
The clinical and pathologic pancreatic abnormalities investigated are 




There was neither historical nor clinical evidence of diabetes melli- 
tus in the 9 patients with pancreatic siderosis in contrast to the posi¬ 
tive family histories and clinical indications of diabetes in several of 
the 31 patients without pancreatic siderosis» Pathologically, however, 
three (43%) of the seven cases of pancreatic siderosis for which post-mor¬ 
tem protocols were available were reported as having slight to marked pan¬ 
creatic fibrosis. This contrasts with the lower incidence (24%) of pan¬ 
creatic fibrosis in cases without siderosis. Of interest, the frequency 
of pancreatic siderosis had no effect on the frequency of hepatic "glycogen 
nuclei." 
Table 3 
Table 3 summarized the relation of many clinical aspects of portal 
cirrhosis and hemochromatosis to the incidence and extent of hepatic 
and pancreatic siderosis in 60 patients with portal cirrhosis. 
This sample was comprised of 55 white and 5 Negro patients--32 men and 
28 women. The median age in years for white men was 57; the mean was 58.6. 
For white women the median age was 49 years, the mean being 52.7. The 
difference in mean ages between the two sexes (5.9 years) did not prove 
to be statistically significant, although it is probable that if the older 
age for women in the general population were taken into consideration 
this difference of 5.9 years would attain statistical significance. The 
cases with little or no hepatocellular iron were fairly evenly distributed 
among the sex and age groups. Both male and old age predominance became 
evident, however, in the cases with marked hepatocellular siderosis. 
The incidence of patients with a prolonged excessive alcoholic intake 
was uniformly high in all categories of hepatic iron deposition. The pres¬ 
ence of parenchymal iron was associated with an incidence of poor diet 
(777o) higher than that for cases with no liver iron (507o) or with only 
o 
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Kupffer cell iron (167,). 
The frequency of a history of fluid retention correlated slightly 
with the incidence of iron in either parenchymal or reticuloendothelial 
cells. In cases with no hepatic iron the incidence of fluid retention was 
507,; in those with only Kupffer cell iron, 677,; with slight hepatocellular 
iron, 697,; and with marked hepatocellular iron, 837>. 
Jaundice on physical examination was noted more frequently in patients 
with parenchymal siderosis, being observed in 257, of cases with only Kupffer 
cell iron, in 507, of cases with no hepatic iron, and in 867, of cases with 
parenchymal iron. 
Two of the three values for serum iron concentration which were avail¬ 
able were on patients who were without hepatic or pancreatic siderosis. One 
determination was within the normal range (70 meg.7,); the other was elevated 
(140 mcgoT,) but not in the range consistently seen in patients with idio¬ 
pathic hemochromatosis (6). The third serum iron concentration was 130 
meg.7, and was determined in a patient with both slight hepatocellular 
and pancreatic siderosis. 
There was no noteworthy correlation between variations in the inci¬ 
dence of the remaining clinical features (Table 3) and in the frequency 
and extent of hepatic and pancreatic siderosis. Such clinical features in¬ 
cluded: personal history of gastrointestinal bleeding, congestive heart 
failure, and diabetes; family history of hepatic disease, cardiac disease, 
and diabetes; evidence on physical examination of melanoderma, hepatomegaly, 
palpable spleen, fluid retention, testicular atrophy, and cardiac abnor¬ 
mality; laboratory data including low hematocrit, elevated fasting blood 
sugar, and glycosuria; and a course in the hospital including transfusion 
therapy, congestive heart failure, hepatic coma, and gastrointestinal bleed¬ 
ing. 
- 
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In summary: in the sixty cases of portal cirrhosis the liver con¬ 
tained stainable iron in 65% of the cases; in 437. of the cases the par¬ 
enchymal cells were involved. Pancreatic iron was found in 237. and 
splenic iron in 847. of the forty cases in which microscopic sections of 
these organs were available. Pathologically, the presence of hepato¬ 
cellular iron was associated with an increased incidence (as compared to 
that in cases without hepatocellular iron) of hepatic "glycogen nuclei," 
pancreatic siderosis, and splenic siderosis; with an increased extent of 
hepatic fibrosis and splenic siderosis; and with a decreased incidence of 
hepatocellular fatty change and alcoholic hyaline. The presence of Kup- 
ffer cell iron was correlated with an altered incidence of only one patho¬ 
logic parameter: splenic siderosis. Pancreatic siderosis was accompanied 
by an increased frequency of pancreatic fibrosis. Regarding clinical 
features, a correlation was apparent between the presence of marked hep¬ 
atocellular siderosis and increased incidence of advanced age, male sex, 
histories of poor diet and fluid retention, and jaundice on physical exam¬ 
ination. 
By way of comparison, the 28 cases of non-portal cirrhosis encountered 
in this study are shown in Table 4. There were nine patients with post¬ 
necrotic cirrhosis, seven with cardiac cirrhosis, and three with biliary 
cirrhosis; nine additional cases could not be morphologically diagnosed 
with assurance and were labeled "unclassified." 
The incidence of stainable hepatic iron in post-necrotic cirrhosis 
was comparable to that in portal cirrhosis in regard to both total hepatic 
(67%) and hepatocellular (44%) iron content. The cases of cardiac cirrho¬ 
sis (all with histories of long-standing hepatic congestion), however, 
were remarkably free of hepatic siderosis; five of the seven cases exhi¬ 
bited no hepatic iron, and only one had hepatocellular iron. Two of the 
<% . - .. *. 
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three cases of hiliary cirrhosis were without hepatic iron; in the third 
there was slight hepatocellular iron. 
Of the twelve pancreases studied in the cases of classified non¬ 
portal cirrhosis, only three (one in each type of cirrhosis) were siderotic, 
all three appearing in cases with ]ivers free of iron. 
Eleven spleens in these same types of cirrhosis were examined. All 
four of the spleens containing narked amounts of iron were associated with 





Three major aspects of hemochromatosis will be discussed: its defi¬ 
nition, its pathogenesis, and its relationship to portal cirrhosis,, Utili¬ 
zing the observations made during this retrospective investigation, these 
general phases will be covered and the 5 more limited objectives of the 
study emphasized,, 
Definition or diagnostic criteria. At the time of the publication of Shel¬ 
don's monograph in 1935, the basis for the diagnosis of hemochromatosis 
was the clinical triad of cirrhosis, diabetes mellitus and bronze pigmen¬ 
tation (3)o However, the frequent absence of one or more of these features 
in pathologically-established cases, and the occasional concurrence of all 
3 in patients with simple cirrhosis pointed up the necessity for more ex¬ 
act pathologic and chemical diagnostic parameters. Many authors, most 
notably Finch and Finch (6), have stressed the demonstration of hepatic 
cirrhosis and hemosiderosis as being critical in definitive diagnosis. 
When confronted with these features in atypical cases, however, they have 
sought confirmation in laboratory determinations such as serum iron content, 
serum iron-binding protein saturation and bone marrow iron content. Sim- 
iliarly, Dubin (7) has advocated resolution of pathological uncertainty 
by the use of iron tolerance tests. 
Purely morphologic features have formed the basis of diagnosis in the 
studies of Kleckner e£ al^ (12) and, more recently, MacDonald and Mallory 
(13). These latter investigators have formulated a rather rigid and re¬ 
stricting diagnostic tetrad, including: portal cirrhosis; siderosis of 
hepatic parenchymal, bile duct and stromal cells; pancreatic siderosis and 
fibrosis; and parenchymal siderosis in other organs. Neither clinical nor 
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functional factors were considered vital in the diagnosis by these au¬ 
thors. 
These conflicts seem to indicate that no set of criteria, clinical, 
biochemical or morphologic, definetfadequately the disease or syndrome of 
hemosiderosis. The current study further emphasizes this diagnostic dil¬ 
emma. Thus, over 407, of these patients with well-established Laennec's 
cirrhosis had abnormal liver cell iron content, many having hemosiderin 
in Kupffer cells and stomal tissue as well. Further, two-thirds of those 
with hepatocellular siderosis had pancreatic siderosis, many having pan¬ 
creatic fibrosis and splenic hemosiderosis in addition. Morphologically, 
therefore, a spectrum of parenchymal iron-loading and tissue damage (as 
manifested by fibrosis) exists. On the one extreme is "pure" portal cirr¬ 
hosis; on the other is "typical" hemochromatosis, with hepatic and pancrea¬ 
tic siderosis and fibrosis. Varying combinations of parenchymal and stomal 
changes exist between these two extremes, making any current set of cri¬ 
teria appear arbitrary and inadequate. The frequent occurrence of Kupffer 
cell and splenic hemosiderosis, even in cases without transfusion or iron 
therapy, seems to invalidate Dubin's concept (7) that reticuloendothelial 
siderosis separates "hemosiderosis" from "hemochromatosis." Similar 
observations have been well*summarized by Bell (9). Occasional demonstra¬ 
tion of hepatocellular iron and pancreatic changes in patients with non¬ 
portal cirrhosis (Table 4) further obscures the previouslyfestablished 
morphologic classifications. 
Pathogenesis. The morphologic points of departure for most theories of 
the pathogenesis of hemochromatosis have been the parenchymal siderosis 
and fibrosis of the liver and pancreas. Thus, various investigators 
have sought to relate the obvious over-retention of iron, the accumulation 
of hemosiderin in liver and pancreatic cells, and tissue damage as mani- 
- 




fested by cell loss and connective tissue over-growth. 
Cell damage induced by "excessive" deposits of iron-containing sub¬ 
stances has been regarded as the primary pathophysiologic phenomenon by 
many workers. Although not original with him, Sheldon (3) popularized this 
theory in his monograph, suggesting that the initial overload stemmed from 
an "internal error of metabolism." Indeed, later investigations have con¬ 
firmed, in certain patients, the striking over-absorption of ingested iron 
across the intestinal mucosal barrier (14), thereby validating Sheldon’s 
hypothesis. However, despite prolonged and massive iron feeding (14) and 
injection (13) in experimental animals, definite hepatic or pancreatic cell 
damage and fibrosis have not been demonstrated with certainty. Perhaps fur 
ther refuting the iron-excess-cell damage etiologic concept is the finding 
here of no hepatic cell necrosis (^lallory bodies) in livers with heavy 
iron deposition. On the other hand, the coincidence of advanced hepatic 
fibrosis and siderosis and the less constant pancreatic siderosis and scarr¬ 
ing might be interpreted as evidence that iron had, in the past, pro¬ 
duced cell death and resultant fibrosis. Certainly, however, the major 
clinical manifestations of hepatic disease in these patients could be well- 
explained by the many parenchymal and stomal changes that were unaccom¬ 
panied by significant siderosis. 
Structural and functional changes of the liver itself have been con¬ 
sidered by some as primary in the evolution of hemochromatosis. Early in 
this century, Simmonds (8) described hemochromatosis as simply a variant of 
portal cirrhosis, and others (15) postulated that hepatic fibrosis induced, 
in some undefined manner, abnormalities of iron metabolism. More re¬ 
cently, Rather (16) emphasized the possible sequence of liver damage - 
iron overload, indicating that intestinal iron absorption was often ex¬ 







mal experiments reported by Goldberg and Smith (17) have given strong 
support to this concept, leading them to postulate that hepatic injury 
(dietary, toxic or unknown) leads to both increased intestinal absorp¬ 
tion and tissue binding of iron, with resultant hemosiderosis. In the 
current clinico-pathological survey, liver disease was (by definition) 
present throughout. Nonetheless, the impression was gained that various 
degrees of hepatocellular and pancreatic parenchymal siderosis were simply 
engrafted on the underlying cirrhotic process. In general, the most 
cirrhotic livers contained the most parenchymal iron, but actively-de¬ 
generating cells did not seem unusually vulnerable to iron deposition. 
Portal cirrhosis is known to be accompanied frequently by pancreatic 
fibrosis (18); hence, the pancreatic siderosis seen might well be secon¬ 
dary rather than primary. The deposition of hemosiderin in the liver, pan¬ 
creas and spleen of many of the cirrhotic patients would, it seems, lend 
credence to the idea that hepatic disease, at least in some phases of 
activity, promotes abnormal intestinal absorption of iron and deposition 
of hemosiderin in tissue sites. These observations do not establish 
any definite relationship between the clinical and laboratory manifesta¬ 
tions characteristic of hemochromatosis and morphologic alterations in 
the liver and pancreas. 
Portal Cirrhosis and Hemochromatosis. Morphologically, aside from iron 
deposition, there is no constant feature which distinguishes the cirrhosis 
of unquestionable hemochromatosis from non-pigmentary portal (Laennec's) 
cirrhosis. Most observers have emphasized the rarity of alcoholic hyaline 
(^Mallory body") formation in hemochromatosis; this series, in which none 
of the cases of hepatic siderosis had alcoholic hyaline, tends to confirm 
this. MacDonald and Mallory (13) and Klechner et al (12), however, have 











hemochromatosis. Pancreatic fibrosis occurs frequently in uncomplicated 
portal cirrhosis (18) and can not be considered unique to hemochromatosis. 
In addition, as shown in this study, pancreatic siderosis may be present in 
simple portal cirrhosis. Thus, there is no clear morphologic separation 
between pigmented and non-pigmented portal cirrhosis. 
Clinically, patients with portal cirrhosis and marked hepatic siderosis 
were set apart in several ways from those with portal cirrhosis alone. 
Histories of poor diet and fluid retention and physical evidence of jaun¬ 
dice were slightly more common in the former group. More striking, however, 
was the definite predominance of males (6/7) in the cases of marked hepato¬ 
cellular siderosis. Thus, these cases seem a connecting link between portal 
cirrhosis, in which roughly equal numbers of males and females are affected 
(19,20), and hemochromatosis, in which about 90% of reported patients 
have been males (6,12). Otherwise, all the clinical manifestations con¬ 
sidered characteristic of hemochromatosis (cirrhosis, diabetes, skin pig- 
are 
mentation, heart disease)^also present in uncomplicated portal cirrhosis (9). 
SUMMARY 
In retrospective studi^# of 60 post-mortem cases of portal cirrhosis 
abnormal parenchymal hepatic iron was present in 43%. Twenty-three per 
cent of the cases studied had pancreatic siderosis, frequently associated 
with fibrosis, and 84% had splenic siderosis. Morphologically, hepatocellular 
iron was associated with striking hepatic fibrosis and pancreatic and splenic 
siderosis. 
Only an increased incidence of elderly males and slight evidence of 
hepatocellular dysfunction (fluid retention and jaundice) clinically dis¬ 
tinguished the cases with hepatic siderosis. 
These observations suggest that the clinico-pathologic syndrome of 
V / 
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hemochromatosis blends imperceptibly with that of non-pigmentary portal 
cirrhosis. It seems that portal cirrhosis in some way predisposes to in¬ 
creased iron absorption and tissue deposition. 

Table 1 
























None 35 58% 14 25 8 2 24 23 1 8 42% 24 5 16 3 
no liver iron 21 35% 9 16 5 1 11 10 1 7 64% 10 4 5 1 
Kupffer cells only 14 23% 5 9 3 1 13 13 0 1 12% 14 1 11 2 
Slight (1-2+) 18 30% 9 15 0 3 10 6 4 4 31% 14 1 11 2' 
Marked (3-4+) 7 12% 5 2 0 3 6 2 4 1 25% 6 1 2 3 
Total 60 100% 28 42 8 8 40 31 9 13 36% 44 7 29 8 
*7o z Percentage of all patients for whom autopsy reports are available. 
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Possible Clinical Aspects of Hemochromatosis Correlated With Hepa 
Pancreatic Stainable Iron in Patients With Portal Cirrhosis 
White Women 
Tissue Iron No. of 57 and 58 and 49 and 





excess alco- poor 




No hepatocellular iron 
no liver iron 
without pancreatic iron 
with pancreatic iron 
Kupffer cell iron only 
without pancreatic iron 
with pancreatic iron 
Slight hepatocellular iron (1-2+) 
without pancreatic iron 
with pancreatic iron 
Marked hepatocellAar iron (3-4+) 
without pancreatic iron 























































One additional chart available. 
The denominator = number of men with available charts, 
Hct. < 307. 

Table 4 













no liver iron 3 3 + SS 
Kupffer cells only 2 2 00 MM 
Post-necrotic slight hepatocellular 4 4 0000 oos 
marked hepatocellular 0 - - - 
no liver iron 5 1 + 0 
Kupffer cells only 1 1 0 M 
Cardiac slight hepatocellular 1 1 0 M* 
marked hepatocellular 0 - - - 
no liver iron 2 2 + - 
Kupffer cells only 0 - - - 
Biliary slight hepatocellular 1 0 0 S 
marked hepatocellular 0 - - - 
no liver iron 5 2 00 00 
Kupffer cells only 1 0 0 M 
Unclassified slight hepatocellular 1 - - - 
marked hepatocellular 3 1 4+ OM 
* This case also exhibited Kupffer cell iron 
S r Slight 





_ . : .. 
BIBLIOGRAPHY 
1. Trousseau, A. "Glycosurie; diab^te sucre." Clinique Med. de l'Hotel- 
Dieu de Paris, 2:663, 1865. 
2. von Recklinghausen. "Uber Hamochromatose." Tageblatt de Deutsch. 
Naturforscher und Arzte in Heidelberg, p. 324, 1889. 
3. Sheldon, J. H. "HaemochromatosisOxford Univ. Press, 1935* 
4. Hanot, V. and Schachmann, M. "Sur la cirrhose pigmentaire dans le 
diab^te sucr£." Arch, de Physiol. Norm, et Path., 7:50, 1886. 
5. Bothwell, T. H. "The Relationship of Transfusional Hemosiderosis 
to Idiopathic Hemochromatosis." South African J. Clin. Sc., 4: 
53, 1953. 
6. Finch, S. C. and Finch, C. A. "Idiopathic Hemochromatosis, an Iron 
Storage Disease." Medicine, 34:381, 1955• 
7. Dubin, I. N. "Idiopathic Hemochromatosis and Transfusion Siderosis." 
Am. J. Clin. Path., 25:524, 1955* 
8. Simmonds, M. "Uber Bronzediabetes und Pigmentcirrhose." Berl. klin. 
Woch., 46:531, 1909. 
9. Bell, E. T. "The Relation of Portal Cirrhosis to Hemochromatosis and 
to Diabetes Mellitus." Diabetes, 4:435, 2955* 
10. Gomori, G. "Microscopic Histochemistry; Principles and Practice." 
Univ. of Chicago Press, 1952. 
11. Mallory, G. K. "The Liver and Biliary Tract." In A Textbook of 
Pathology (edited by S. L. Robbins), 1st ed., 1957* 
12. Kleckner, Jr., M. S., Baggenstoss, A. H., and Weir, J. F. "Hemochrom¬ 
atosis and Transfusional Hemosiderosis: A Clinical and Pathologic 
Study." Am. J. Med., 16:382, 1954. 
13. MacDonald, R. A. and Mallory, G. K. "Hemochromatosis and Hemosiderosis." 
Arch. Int. Med., 105:686, i960. 
14. Demulder, R. "Iron." Arch. Int. Med., 102:254, 1958. 
15. Kinney, T. D., Hegsted, D. M., and Finch, C. A. "The Influence of Diet 
on Iron Absorption." J. Exp. Med., 90:137, 1949* 
16. Muir, R. and Shaw Dunn, J. "The Iron Content in the Organs in Bronzed 
Diabetes." J. Path, and Bact., 19:226, 1914. 
l 
; 




17. Rather, L. J. "Hemochromatosis and Hemosiderosis: Does Iron Overload 
Cause Diffuse Fibrosis of the Liver?" Am. J. Med., 21:857* 1956. 
18. Goldberg, L. and Smith, J. P. "Iron Overloading and Hepatic Vulner¬ 
ability." Am. J. Path., 36:125, i960. 
19. Stimson, J. C., Baggenstoss, A. H., and Morlock, C. G. "Pancreatic 
Lesions Associated with Cirrhosis of the Liver." Am. J. Clin. 
Path., 22:117, 1952. 
20. Boles, R. S., Crew, R. S., and Dunbar, W. "Alcoholic Cirrhosis." 
J.A.M.A., 134:670, 1947. 
21. Hall, E. M., Olsen, A. Y., and Davis, F. E. "Portal Cirrhosis." Am. 




. , . . . 






YALE MEDICAL LIBRARY 
Manuscript Theses 
Unpublished theses submitted for the Master's and Doctor's degrees and 
deposited in the Yale Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 

